ERR Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-0857
Full Text
Open PDFAbstract
Available in full text
Date
November 5, 2015
Authors
Publisher
American Association for Cancer Research (AACR)